Janus Henderson Global Life Sciences Fund

A $acc ISIN code: IE0009355771

Investment objective

This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve similar or lower volatility relative to our peers.

Overview

Before you invest

Share class:

Key documents

All documents
ISIN code: IE0009355771A $acc Currency USD NAV 33.2800 Change
-
Price date 23/05/2019
 
ISIN code: IE00BFTCPJ56A SGD Acc Currency SGD NAV 9.9400 Change
-
Price date 23/05/2019
ISIN code: IE00BJT1NW94A SGD Acc Hedged Currency SGD NAV 9.7600 Change
-
Price date 23/05/2019

Ratings and awards

Morningstar 5 Star

Key data

Asset class Equities
Structure Irish Investment Company
Launch date 31/03/2000
Base currency USD
Sector Morningstar Europe OE Sector Equity Healthcare
Benchmark MSCI World Health Care
Pricing basis -

A $acc

Distribution type Accumulation
ISIN code IE0009355771
WKN Code 935590
Valoren Code 1060639
Initial charge 5
Annual charges 1.5
Launch date 31/03/2000
Dividend pay dates N/A
XD dates N/A
Currency USD
Performance FeeCertain classes within a fund may be able to charge a performance related management fee, which becomes payable when that class outperforms its performance fee benchmark and previous high watermark (where applicable).N/A
Minimum Lump Sum USD2,500.00

A SGD Acc

Distribution type Accumulation
ISIN code IE00BFTCPJ56
WKN Code A2PFGS
Valoren Code 46795928
Initial charge 5
Annual charges 1.5
Launch date 11/03/2019
Dividend pay dates N/A
XD dates N/A
Currency SGD
Performance FeeCertain classes within a fund may be able to charge a performance related management fee, which becomes payable when that class outperforms its performance fee benchmark and previous high watermark (where applicable).N/A

A SGD Acc Hedged

Distribution type Accumulation
ISIN code IE00BJT1NW94
WKN Code A2PFGT
Valoren Code 46796359
Initial charge 5
Annual charges 1.5
Launch date 11/03/2019
Dividend pay dates N/A
XD dates N/A
Currency SGD
Performance FeeCertain classes within a fund may be able to charge a performance related management fee, which becomes payable when that class outperforms its performance fee benchmark and previous high watermark (where applicable).N/A

Manager(s)

General risks
  • ​The value of the Funds and the income from them is not guaranteed and may fall as well as rise. You may get back less than you originally invested.
  • ​Past performance is not a guide to future performance.
  • ​For detailed product information including the risks associated with investing please read the relevant Prospectus or Annual Report.
  • Before investing in any of our funds you should satisfy yourself as to the suitability and the risks involved, you may wish to consult a financial adviser.
  • Third party data is believed to be reliable, but its completeness and accuracy is not guaranteed.
Specific risks
Specific risks

Important message